Count Me In: Partnering with Patients to Accelerate Cancer Research

Count Me In is a research initiative pursuing an innovative, patient-partnered approach to cancer research. Hear from Dana-Farber Cancer Institute’s Nikhil Wagle, MD, Director of Count Me In, to learn how this initiative is bringing patients and researchers together as partners to accelerate discoveries — allowing cancer patients anywhere in the United States or Canada to safely and easily share their medical information, personal experience, and tumor samples for genetic analysis, propelling progress against cancer.

To learn more, visit the Revolutionary Science section of this site.

Give Now

Thank you for your interest in learning more about The Dana-Farber Campaign. You have been added to our email list and will receive updates on ways to join us in defying cancer. You can unsubscribe at any time.

There has been an issue submitting your request. Please try again.

Founded in Boston in 1947, Dana-Farber is a principal teaching affiliate of Harvard Medical School and a federally designated Comprehensive Cancer Center that develops and disseminates innovative patient therapies and scientific discoveries throughout the world. About Our Patient Stories: Dana-Farber shares patient stories which may include descriptions of actual medical results. Dana-Farber provides personalized care for each patient based on their unique needs; their experiences and results will vary.

At Dana-Farber we are committed to an inclusive community where human differences are valued and celebrated, and where all are welcome. We work every day to create an innovative, caring, and inclusive environment where each patient, family, and staff member feels valued and respected.